🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Australia / NCT06830252
Starting soon Not applicable

Neurological Impact of Weight Reduction and Fitness Interventions

NCT06830252 · tracked via the Priya Life Science Australia tracker
Phase
Not applicable
Started
2025-02
Last updated
2025-02-17

Condition(s) studied

Obesity and Overweight

Investigational drug(s) / intervention(s)

Exercise

Exercise: Exercise.

Study summary

This study will test how significant weight loss through bariatric surgery, combined with a personalised exercise program, affects brain inflammation. Th investigators want to understand the connection between obesity-related body inflammation, metabolic issues, and brain inflammation and function.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * 18-80 years of age. * Eligible for bariatric surgery. * Willingness to provide informed consent and willingness to participate and comply with the study requirements Exclusion Criteria: * Unable to undertake MRI due to size restrictions i.e., shoulder width more than 70 cm. * History or clinical manifestation of any other significant metabolic, hematologic, pulmonary, cardio- vascular, gastrointestinal, neurologic, immune, hepatic, renal, urologic, muscular, and joint disorders, or cancer that, in the opinion of the investigator, would make the candidate ineligible for the study. For example, significant joint pain could interfere with adherence to the exercise program. * Have objectively assessed cognitive impairment as assessed by the Montreal Cognitive Assessment (MoCA) i.e., total score less than 26. * Non-MRI-compatible implanted devices or implants. * Inability to exercise via supine ergometer. * Claustrophobia. * Psychiatric or behavioural problems (history of drug and alcohol abuse, eating disorder). * Breastfeeding or pregnant women, or those intending to become pregnant before the scheduled end of the intervention. * Unwilling to be assigned at random to the exercise or control intervention. * Unwilling or unable to adhere to the rigors of the exercise intervention or evaluation schedule over the entire one-year period. * Concurrent participation in any other interventional study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Charles Perkins Centre Clinic Royal Prince Alfred Hospital New South Wales

More University of Sydney trials in Australia

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06830252 on ClinicalTrials.gov ↗ ← All trials in Australia